Industry News

Bausch + Lomb, Alfa Instruments Announce Distribution Agreement for Intraocular Dyes

Bausch + Lomb and Alfa Instruments announced that they have signed an exclusive distribution agreement under which Bausch + Lomb will market and distribute Vitreocare, a line of surgical intraocular dyes from Alfa Instruments.

Bausch + Lomb, Alfa Instruments Announce Distribution Agreement for Intraocular Dyes
September 05, 2022
Bausch + Lomb Forms Strategic Partnership With Munich Surgical Imaging GmbH

Bausch + Lomb has formed a strategic partnership with Munich Surgical Imaging GmbH (MSI)—a wholly‐owned subsidiary of Heidelberg Engineering GmbH.

Bausch + Lomb Forms Strategic Partnership With Munich Surgical Imaging GmbH
August 31, 2022
Glaukos Licenses Iveena's Investigational Keratoconus Therapy

Glaukos announced that it obtained an exclusive global license to develop and market IVMED-80, an experimental pharmacologic therapy for keratoconus from iVeena Delivery Systems.

Glaukos Licenses Iveena's Investigational Keratoconus Therapy
August 25, 2022
Haag-Streit Opens a New Surgical Microscope Production Site in Switzerland

Haag-Streit has announced the opening of a new state-of-the-art microscope production site in Aesch, Switzerland.

Haag-Streit Opens a New Surgical Microscope Production Site in Switzerland
August 25, 2022
First Patients Treated With ALLY Adaptive Cataract Treatment System

The Eye Institute of West Florida's Robert Weinstock, MD, completed the first commercial cases using the ALLY Adaptive Cataract Treatment System, according to Lensar. 15 laser-assisted cataract surgery procedures were carried out by Dr. Weinstock.

First Patients Treated With ALLY Adaptive Cataract Treatment System
August 17, 2022
Opthea Announces Financing Deals for New Drug Candidate in Wet AMD

Opthea announced two financing deals to advance OPT-302, a drug candidate for wet age-related macular degeneration (AMD).

Opthea Announces Financing Deals for New Drug Candidate in Wet AMD
August 16, 2022
ProQR to Focus Exclusively on Axiomer RNA-editing Technology

Following comments from the European Medicines Agency (EMA) about sepofarsen, ProQR Therapeutics released an update on its ophthalmology activities and will now exclusively concentrate on its Axiomer RNA-editing technology platform.

ProQR to Focus Exclusively on Axiomer RNA-editing Technology
August 12, 2022
Orbis and Alcon Begin Two-Week Training for Caribbean Eye Care Teams

On August 8, Orbis International launched its first on-site training program on board the Flying Eye Hospital, a fully accredited ophthalmic teaching hospital on board a plane, with assistance from Alcon.

Orbis and Alcon Begin Two-Week Training for Caribbean Eye Care Teams
August 09, 2022
HOYA Vision Care Forms Joint Venture with Jiangsu Sigo Optical

HOYA Vision Care has entered into a strategic joint venture with Chinese eyeglass lens manufacturer Jiangsu Sigo Optical's (JSO) Founder and Chief Executive Officer Liu Jianzhong.

HOYA Vision Care Forms Joint Venture with Jiangsu Sigo Optical
August 09, 2022
Clearside Biomedical Enters Into Financing Agreement with HealthCare Royalty Partners

Clearside Biomedical announced it has entered into an agreement with HealthCare Royalty Partners in a deal worth up to $65 million.

Clearside Biomedical Enters Into Financing Agreement with HealthCare Royalty Partners
August 09, 2022
More